MGRX — Mangoceuticals Share News
0.000.00%
Last trade - 00:00- $5.43m
- $5.24m
- $0.46m
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:25 AM
NASDAQ RESUMED AT 10:25 AM
NASDAQ RESUMED AT 10:23 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:23 AM
NASDAQ RESUMED AT 10:22 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:22 AM
NASDAQ RESUMED AT 10:17 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:17 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:16 AM
Brief: Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Clarity Ventures
Brief: Mangoceuticals, Inc. Announces Percent Patent Filing For MGX-0024 Antiviral Technology To Include Inhibiting Respiratory Or Orally Acquired Virus Infection In Animals Or Birds
Brief: Mangoceuticals’ MGX-0024 Achieves Zero Respiratory-Related Mortality, Shows H5n1 Prophylactic Benefit
Mangoceuticals surges on strong sales of injectable testosterone therapy
Brief: Mangoceuticals Announces Partnership With The Cube Group
Brief: Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk